Second Genome is Taxon Biosciences's biggest rival. Second Genome was founded in Brisbane, California} in 2009. Second Genome operates in the Biotechnology industry. Compared to Taxon Biosciences, Second Genome generates $3M more revenue.
Seres Therapeutics is Taxon Biosciences's #2 rival. Seres Therapeutics's headquarters is in Cambridge, Massachusetts, and was founded in 2010. Seres Therapeutics competes in the Biotechnology field. Seres Therapeutics generates 675% of Taxon Biosciences's revenue.
No recent acquisitions found related to Taxon Biosciences
No recent investments found related to Taxon Biosciences